21.20.Z - Manufacture of medicines and other pharmaceutical products
10.89.Z - Manufacture of other food products not elsewhere classified
20.14.Z - Manufacture of other organic basic chemicals
20.42.Z - Manufacture of perfumes and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical substances
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
68.20.Z - Rental and operating of own or leased real estate
72.19.Z - Other research and experimental development on natural sciences and engineering
82.92.Z - Packaging activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 3,6 | 9,1 | 13,7 | 49,6 |
EBITDA | 5 | 11,1 | 16 | 44,7 |
Short time liabilities | 10,3 | 7,8 | 5,6 | -27,3 |
Equity capital | 25,9 | 32,6 | 43,1 | 32,2 |
Operating profit (EBIT) | 4,1 | 10 | 14,6 | 45,9 |
Assets | 41,1 | 45,4 | 55 | 21,1 |
Net profit (loss) | 3,1 | 7,1 | 11 | 54,5 |
Cash | 1,8 | 2 | 4 | 104,6 |
Net income from sale | 41,3 | 53 | 62,2 | 17,2 |
Liabilities and provisions for liabilities | 15,2 | 12,8 | 11,9 | -7,1 |
Working assets | 17,5 | 21,5 | 27,8 | 29,1 |
Depreciation | 0,9 | 1,1 | 1,4 | 33,2 |
% | % | % | p.p. | |
Profitability of capital | 11,9 | 21,8 | 25,5 | 3,7 |
Equity capital to total assets | 63 | 71,7 | 78,3 | 6,6 |
Gross profit margin | 8,8 | 17,2 | 22 | 4,8 |
EBITDA Margin | 12,2 | 20,9 | 25,8 | 4,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 91 | 53 | 33 | -20 |
Current financial liquidity indicator | 1.5441232919692993 | 2.4579529762268066 | 4.1667656898498535 | 1,7 |
Net dept to EBITDA | 1.2123379707336426 | 0.1816181093454361 | -0.009957694448530674 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane